Join
Oncorus Inc. logo

ONCR

NASDAQ

Oncorus Inc.

SectorHealth CareIndustry Medicinal Chemicals and Botanical Products IPO2020
$0.12-0.01 (-10.15%)
News25/Ratings0

Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Latest news

25 items

ONCR FAQ

6 questions
  • What does Oncorus Inc. do?
    Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial...
  • Where does ONCR stock trade?
    Oncorus Inc. (ONCR) is listed on NASDAQ.
  • What sector and industry is ONCR in?
    Oncorus Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.
  • When did Oncorus Inc. go public?
    Oncorus Inc. (ONCR) completed its IPO in 2020.
  • What companies are similar to ONCR?
    Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare ONCR side-by-side with any of them on Quantisnow.
  • How can I track ONCR on Quantisnow?
    Quantisnow aggregates Oncorus Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ONCR to receive live email and push alerts on every new disclosure.